nach oben

Spektrum der Augenheilkunde

Erschienen in:

01.03.2015 | themenschwerpunkt

Neue Behandlungsprotokolle der Hornhautvernetzung (Corneal Crosslinking)

verfasst von: Assoc.-Prof. Priv.-Doz. Dr. Gerald Schmidinger, Niklas Pircher

Erschienen in: Spektrum der Augenheilkunde | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

In den letzten Jahren hat sich die Hornhautvernetzung (Corneal Crosslinking/CXL) zur Behandlung von ektatischen Hornhauterkrankungen in der Hornhautchirurgie etabliert. Die Effektivität dieses Eingriffs konnte in zahlreichen Studien belegt werden. Rezent wurden unterschiedliche Behandlungsprotokolle vorgestellt, welche die Sicherheit durch eine transepitheliale Behandlung verbessern sollen. Ebenso wurden beschleunigte Verfahren vorgestellt, um die Behandlungsdauer signifikant zu reduzieren. In dieser Übersichtsarbeit werden transepitheliale Behandlungsprotokolle sowie beschleunigte Behandlungsprotokolle beschrieben und der Stand der Evidenz beurteilt.

Vorheriger Artikel Femtosekundenlaser assistierte tiefe Anteriore Lamelläre Keratoplastik (FALKe) – die Linzer „Hybrid Technik“

Nächster Artikel Die Boston-Keratoprothese: eine Übersicht auf der Basis eigener Erfahrungen

Gokhale NS. Epidemiology of keratoconus. Indian J Ophthalmol. 2013;61(8):382–3.CrossRefPubMedCentralPubMed

Wagner H, Barr JT, Zadnik K. Collaborative longitudinal evaluation of keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. 2007;30(4):223–32.CrossRefPubMedCentralPubMed

McMahon TT, et al. Longitudinal changes in corneal curvature in keratoconus. Cornea. 2006;25(3):296–305.CrossRefPubMed

Sporl E, et al. [Increased rigidity of the cornea caused by intrastromal cross-linking]. Ophthalmologe. 1997;94(12):902–6.CrossRefPubMed

Schmut O, et al. Die Therapie des Keratokonus mit Riboflavin und UV-A-Licht – biochemische Aspekte. Spektrum der Augenheilkunde. 2009;23(5):337–42.CrossRef

Wollensak G, Sporl E, Seiler T. [Treatment of keratoconus by collagen cross linking]. Ophthalmologe. 2003;100(1):44–9.CrossRefPubMed

Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29(9):1780–5.CrossRefPubMed

Spoerl E, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26(4):385–9.CrossRefPubMed

Iseli HP, et al. Efficacy and safety of blue-light scleral cross-linking. J Refract Surg. 2008;24(7):752–5.

10.

Asri D, et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg. 2011;37(12):2137–43.CrossRefPubMed

11.

Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011;37(1):149–60.CrossRefPubMed

12.

Caporossi A, et al. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149(4):585–93.CrossRefPubMed

13.

Wittig-Silva C, et al. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg. 2008;24(7):720–5.

14.

Goldich Y, et al. Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up. Cornea. 2012;31(6):609–14.CrossRefPubMed

15.

Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358–62.CrossRefPubMed

16.

Perez-Santonja JJ, et al. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009;35(6):1138–40.CrossRefPubMed

17.

Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg. 2009;35(3):588–9.CrossRefPubMed

18.

Faschinger C, Kleinert R, Wedrich A. [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome]. Ophthalmologe. 2010;107(10):951–2, 954–5.CrossRefPubMed

19.

Seiler TG, et al. [Complications of corneal cross-linking]. Ophthalmologe. 2013;110(7):639–44.CrossRefPubMed

20.

Baiocchi S, et al. Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg. 2009;35(5):893–9.CrossRefPubMed

21.

Grass GM, Wood RW, Robinson JR. Effects of calcium chelating agents on corneal permeability. Invest Ophthalmol Vis Sci. 1985;26(1):110–3.PubMed

22.

Raiskup F, Pinelli R, Spoerl E. Riboflavin osmolar modification for transepithelial corneal cross-linking. Curr Eye Res. 2012;37(3):234–8.CrossRefPubMed

23.

Mastropasqua L, et al. Corneal cross-linking: intrastromal riboflavin concentration in iontophoresis-assisted imbibition versus traditional and transepithelial techniques. Am J Ophthalmol. 2014;157(3):623–30 e1.CrossRefPubMed

24.

Hayes S, et al. Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg. 2008;34(4):657–61.CrossRefPubMed

25.

Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35(3):540–6.CrossRefPubMed

26.

Mastropasqua L, et al. Morphological modification of the cornea after standard and transepithelial corneal cross-linking as imaged by anterior segment optical coherence tomography and laser scanning in vivo confocal microscopy. Cornea. 2013;32(6):855–61.CrossRefPubMed

27.

Caporossi A, et al. Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis. Eur J Ophthalmol. 2012;22(Suppl 7):81–8.CrossRef

28.

Touboul D, et al. Corneal confocal microscopy following conventional, transepithelial, and accelerated corneal collagen cross-linking procedures for keratoconus. J Refract Surg. 2012;28(11):769–76.CrossRefPubMed

29.

Mencucci R, et al. Transepithelial riboflavin/ultraviolet. a corneal cross-linking in keratoconus: morphologic studies on human corneas. Am J Ophthalmol. 2013;156(5):874–84 e1.CrossRefPubMed

30.

Filippello M, Stagni E, O’Brart D. Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg. 2012. 38(2):283–91.CrossRefPubMed

31.

Filippello M, et al. Transepithelial cross-linking in keratoconus patients: confocal analysis. Optom Vis Sci. 2012;89(10):e1–7.CrossRefPubMed

32.

Salman AG. Transepithelial corneal collagen crosslinking for progressive keratoconus in a pediatric age group. J Cataract Refract Surg. 2013;39(8):1164–70.CrossRefPubMed

33.

Magli A, et al. Epithelium-off corneal collagen cross-linking versus transepithelial cross-linking for pediatric keratoconus. Cornea. 2013;32(5):597–601.CrossRefPubMed

34.

Caporossi A, et al. Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg. 2013;39(8):1157–63.CrossRefPubMed

35.

Koppen C, et al. Refractive and topographic results of benzalkonium chloride-assisted transepithelial crosslinking. J Cataract Refract Surg. 2012;38(6):1000–5.CrossRefPubMed

36.

Buzzonetti L, Petrocelli G. Transepithelial corneal cross-linking in pediatric patients: early results. J Refract Surg. 2012;28(11):763–7.CrossRefPubMed

37.

Kocak I, et al. Comparison of transepithelial corneal collagen crosslinking with epithelium-off crosslinking in progressive keratoconus. J Fr Ophtalmol. 2014;37(5):371–6.CrossRefPubMed

38.

Acar BT, et al. Can the effect of transepithelial corneal col- 495 lagen cross-linking be improved by increasing the dura- 496 tion of topical riboflavin application? An in vivo confocal 497 microscopy study. Eye Contact Lens. 2014;40(4):207–12.

39.

Kymionis GD, et al. Evaluation of corneal stromal demarcation line depth following standard and a modified-accelerated collagen cross-linking protocol. Am J Ophthalmol. 2014;158(4):671–675.

40.

Arboleda A, et al. Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study. Invest Ophthalmol Vis Sci. 2014;55(4):2731–8.CrossRefPubMed

41.

Cassagne M, et al. Iontophoresis transcorneal delivery technique for transepithelial corneal collagen crosslinking with riboflavin in a rabbit model. Invest Ophthalmol Vis Sci. 2014 Mar 18. pii: iovs.13–12595v1. doi: 10.1167/iovs.13–12595.

42.

Bikbova G, Bikbov M. Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin. Acta Ophthalmol. 2014;92(1):e30–4.CrossRefPubMed

43.

Kanellopoulos AJ. Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg. 2009;25(11):1034–7.CrossRefPubMed

44.

Daxer A, Mahmoud HA, Venkateswaran RS. Corneal crosslinking and visual rehabilitation in keratoconus in one session without epithelial debridement: new technique. Cornea. 2010;29(10):1176–9.CrossRefPubMed

45.

Wollensak G, et al. Biomechanical efficacy of collagen crosslinking in porcine cornea using a femtosecond laser pocket. Cornea. 2014;33(3):300–5.PubMed

46.

Alio JL, et al. Cross-linking in progressive keratoconus using an epithelial debridement or intrastromal pocket technique after previous corneal ring segment implantation. J Refract Surg. 2011;27(10):737–43.CrossRefPubMed

47.

Seiler TG, et al. Intrastromal application of riboflavin for corneal crosslinking. Invest Ophthalmol Vis Sci. 2014;55(7):4261–5.CrossRefPubMed

48.

Schmidinger G, Pachala M, Prager F. Pachymetry changes during corneal crosslinking: effect of closed eyelids and hypotonic riboflavin solution. J Cataract Refract Surg. 2013;39(8):1179–83.CrossRefPubMed

49.

Marshall J, HP Muller D. Corneal collagen cross-linking; past, present, future. 2013: Avedro, Inc.

50.

Jain V, Gazali Z, Bidayi R. Isotonic Riboflavin and HPMC with accelerated cross-linking protocol. Cornea. 2014;33(9):910–3.

51.

Bunsen RW, Roscoe H. Photochemical researches, part V: on the measurement of the chemical action of direct and diffuse sunlight. Proc R Soc Lond. 1862;12:306–12.CrossRef

52.

Wernli J, et al. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci. 2013;54(2):1176–80.CrossRefPubMed

53.

Schumacher S, Oeftiger L, Mrochen M. Equivalence of biomechanical changes induced by rapid and standard corneal cross-linking, using riboflavin and ultraviolet radiation. Invest Ophthalmol Vis Sci. 2011;52(12):9048–52.CrossRefPubMed

54.

Hammer A, et al. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55(5):2881–4.CrossRefPubMed

55.

Tomita M, Mita M, Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg. 2014;40(6):1013–20.CrossRefPubMed

56.

Mita M, Waring GOt, Tomita M. High-irradiance accelerated collagen crosslinking for the treatment of keratoconus: six-month results. J Cataract Refract Surg. 2014;40(6):1032–40.CrossRefPubMed

57.

Elbaz U, et al. Accelerated (9-mW/cm²) corneal collagen crosslinking for keratoconus-A 1-year follow-up. Cornea. 2014;33(8):769–73.CrossRefPubMed

58.

Gatzioufas Z, et al. Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg. 2013;29(12):846–8.CrossRefPubMed

59.

Cinar Y, et al. Accelerated corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol. 2014;33(2):168–71.CrossRefPubMed

60.

Cinar Y, et al. Comparison of accelerated and conventional corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol. 2013;33(3):218–22.

61.

Koller T. Clinical results with an optimized beam-profile, in 9th International Congress of Corneal Cross-Linking. 2013: Dublin.

62.

Sel S, et al. UVA irradiation of riboflavin generates oxygen-dependent hydroxyl radicals. Redox Rep. 2014;19(2):72–9.CrossRefPubMed

63.

Richoz O, et al. The Biomechanical effect of corneal collagen cross-linking (CXL) with riboflavin and UV-A is oxygen dependent. Transl Vis Sci Technol. 2013;2(7):6.CrossRefPubMedCentralPubMed

64.

Kymionis GD, et al. Corneal stroma demarcation line after standard and high-intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg. 2014;40(5):736–40.CrossRefPubMed

65.

Mazzotta C, et al. Pulsed vs continuous light accelerated corneal collagen crosslinking: in vivo qualitative investigation by confocal microscopy and corneal OCT. Eye (Lond). 2014;28(10):1179–83.

Titel: Neue Behandlungsprotokolle der Hornhautvernetzung (Corneal Crosslinking)
verfasst von: Assoc.-Prof. Priv.-Doz. Dr. Gerald Schmidinger
Niklas Pircher
Publikationsdatum: 01.03.2015
Verlag: Springer Vienna
Erschienen in: Spektrum der Augenheilkunde / Ausgabe 1/2015
Print ISSN: 0930-4282
Elektronische ISSN: 1613-7523
DOI: https://doi.org/10.1007/s00717-015-0257-6

Springer Medizin Österreich

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Femtosekundenlaser assistierte tiefe Anteriore Lamelläre Keratoplastik (FALKe) – die Linzer „Hybrid Technik“

Descemet Membran Endothelkeratoplastik (DMEK) und/oder Phakoemulsifikation in phaken Augen mit Hornhautendotheldystrophie

ReLEx SMILE – Refraktive Lentikel Extraktion über Kleinschnittinzision

Die Boston-Keratoprothese: eine Übersicht auf der Basis eigener Erfahrungen

Descemet-Membran-Endothelkeratoplastik (DMEK) – Klinische Ergebnisse der ersten 120 Fälle

State of the Art – Hornhautbanking im Zeitalter der lamellären Keratoplastik